Michail Kokkorakis, MD, PhD(c)

I am a physician–scientist at the University Medical Center Groningen (Netherlands) and an incoming postdoctoral fellow at Yale School of Medicine, Section of Digestive Diseases. My work integrates digital health, artificial intelligence, and translational hepatology to improve how cardiometabolic and liver diseases are predicted, understood, and treated.

During my MD/PhD, I used large-scale clinical and biobank data to develop computational models that identify individuals at high risk of cardiometabolic and hepatic disease. This experience exposed a critical gap: while prediction tools have advanced, hepatology still lacks targeted and effective pharmacotherapies. This insight redirected my focus toward translational research aimed at uncovering biological pathways that can inform clinically more effective prediction, diagnosis, and treatment strategies.

Supported by a Dutch Research Council (NWO Rubicon) fellowship, my postdoctoral work at Yale will investigate lipid–immune interactions in humanized liver models of metabolic and alcohol-associated liver disease, bridging population-level analytics with mechanistic discovery.

Beyond academia, I am motivated by bringing scientific advances to practice, building scalable solutions at the intersection of medicine, data science, and biotechnology